New clues to understanding HIV nonprogressors

Low cholesterol blocks HIV trans infection

Vinayaka R. Prasad, Michael I. Bukrinsky

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

A small percentage of HIV-infected subjects (2 to 15%) are able to control disease progression for many years without antiretroviral therapy. Years of intense studies of virologic and immunologic mechanisms of disease control in such individuals yielded a number of possible host genes that could be responsible for the preservation of immune functions, from immune surveillance genes, chemokines, or their receptors to anti-HIV restriction factors. A recent mBio paper by Rappocciolo et al. (G. Rappocciolo, M. Jais, P. Piazza, T. A. Reinhart, S. J. Berendam, L. Garcia-Exposito, P. Gupta, and C. R. Rinaldo, mBio 5:e01031- 13, 2014) describes another potential factor controlling disease progression: Cholesterol levels in antigen-presenting cells. In this commentary, we provide a brief background of the role of cholesterol in HIV infection, discuss the results of the study by Rappocciolo et al., and present the implications of their findings.

Original languageEnglish (US)
JournalmBio
Volume5
Issue number3
DOIs
StatePublished - Jun 10 2014

Fingerprint

HIV Long-Term Survivors
HIV Infections
Disease Progression
Cholesterol
HIV
Immune System Diseases
Antigen-Presenting Cells
Chemokines
Genes
Therapeutics

ASJC Scopus subject areas

  • Microbiology
  • Virology
  • Medicine(all)

Cite this

New clues to understanding HIV nonprogressors : Low cholesterol blocks HIV trans infection. / Prasad, Vinayaka R.; Bukrinsky, Michael I.

In: mBio, Vol. 5, No. 3, 10.06.2014.

Research output: Contribution to journalArticle

@article{d5dcb7e5bc494b89bcad146a6362620c,
title = "New clues to understanding HIV nonprogressors: Low cholesterol blocks HIV trans infection",
abstract = "A small percentage of HIV-infected subjects (2 to 15{\%}) are able to control disease progression for many years without antiretroviral therapy. Years of intense studies of virologic and immunologic mechanisms of disease control in such individuals yielded a number of possible host genes that could be responsible for the preservation of immune functions, from immune surveillance genes, chemokines, or their receptors to anti-HIV restriction factors. A recent mBio paper by Rappocciolo et al. (G. Rappocciolo, M. Jais, P. Piazza, T. A. Reinhart, S. J. Berendam, L. Garcia-Exposito, P. Gupta, and C. R. Rinaldo, mBio 5:e01031- 13, 2014) describes another potential factor controlling disease progression: Cholesterol levels in antigen-presenting cells. In this commentary, we provide a brief background of the role of cholesterol in HIV infection, discuss the results of the study by Rappocciolo et al., and present the implications of their findings.",
author = "Prasad, {Vinayaka R.} and Bukrinsky, {Michael I.}",
year = "2014",
month = "6",
day = "10",
doi = "10.1128/mBio.01396-14",
language = "English (US)",
volume = "5",
journal = "mBio",
issn = "2161-2129",
publisher = "American Society for Microbiology",
number = "3",

}

TY - JOUR

T1 - New clues to understanding HIV nonprogressors

T2 - Low cholesterol blocks HIV trans infection

AU - Prasad, Vinayaka R.

AU - Bukrinsky, Michael I.

PY - 2014/6/10

Y1 - 2014/6/10

N2 - A small percentage of HIV-infected subjects (2 to 15%) are able to control disease progression for many years without antiretroviral therapy. Years of intense studies of virologic and immunologic mechanisms of disease control in such individuals yielded a number of possible host genes that could be responsible for the preservation of immune functions, from immune surveillance genes, chemokines, or their receptors to anti-HIV restriction factors. A recent mBio paper by Rappocciolo et al. (G. Rappocciolo, M. Jais, P. Piazza, T. A. Reinhart, S. J. Berendam, L. Garcia-Exposito, P. Gupta, and C. R. Rinaldo, mBio 5:e01031- 13, 2014) describes another potential factor controlling disease progression: Cholesterol levels in antigen-presenting cells. In this commentary, we provide a brief background of the role of cholesterol in HIV infection, discuss the results of the study by Rappocciolo et al., and present the implications of their findings.

AB - A small percentage of HIV-infected subjects (2 to 15%) are able to control disease progression for many years without antiretroviral therapy. Years of intense studies of virologic and immunologic mechanisms of disease control in such individuals yielded a number of possible host genes that could be responsible for the preservation of immune functions, from immune surveillance genes, chemokines, or their receptors to anti-HIV restriction factors. A recent mBio paper by Rappocciolo et al. (G. Rappocciolo, M. Jais, P. Piazza, T. A. Reinhart, S. J. Berendam, L. Garcia-Exposito, P. Gupta, and C. R. Rinaldo, mBio 5:e01031- 13, 2014) describes another potential factor controlling disease progression: Cholesterol levels in antigen-presenting cells. In this commentary, we provide a brief background of the role of cholesterol in HIV infection, discuss the results of the study by Rappocciolo et al., and present the implications of their findings.

UR - http://www.scopus.com/inward/record.url?scp=84903954201&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84903954201&partnerID=8YFLogxK

U2 - 10.1128/mBio.01396-14

DO - 10.1128/mBio.01396-14

M3 - Article

VL - 5

JO - mBio

JF - mBio

SN - 2161-2129

IS - 3

ER -